Synthesis, antiproliferative and antiplasmodial evaluation of new chloroquine and mefloquine-based harmiquins Cover

.blurhash-client-img { display: none !important; }

Synthesis, antiproliferative and antiplasmodial evaluation of new chloroquine and mefloquine-based harmiquins

Acta Pharmaceutica

Volume 73 (2023): Issue 4 (December 2023)

By: Kristina Pavić , Goran Poje , Lais Pessanha De Carvalho , Jana Held and Zrinka Rajić

Open Access

|Dec 2023

Authors

Kristina Pavić

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal Chemistry, Zagreb, Croatia

Goran Poje

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal Chemistry, Zagreb, Croatia

Lais Pessanha De Carvalho

University of Tübingen, Institute of Tropical Medicine, Tübingen, Germany

Jana Held

University of Tübingen, Institute of Tropical Medicine, Tübingen, Germany

German Center for Infection Research (DZIF), Tübingen, Germany

Zrinka Rajić

zrinka.rajic@pharma.unizg.hr

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal Chemistry, Zagreb, Croatia

DOI: https://doi.org/10.2478/acph-2023-0035 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 537 - 558

Accepted on: Jun 9, 2023

|

Published on: Dec 26, 2023

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

anti-plasmodial activity,

antiproliferative activity

Related subjects:

Pharmacy, other

© 2023 Kristina Pavić, Goran Poje, Lais Pessanha De Carvalho, Jana Held, Zrinka Rajić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2023): Issue 4 (December 2023)Next article